News
7d
Pharmaceutical Technology on MSNAbbVie expands North Chicago API production with $195m investment
AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North ...
2d
Zacks Investment Research on MSNHere is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
This was the stock's second consecutive day of gains.
Q2 2025 Earnings Call Transcript July 31, 2025 AbbVie Inc. beats earnings expectations. Reported EPS is $2.97, expectations were $2.88. Operator: Good morning, and thank you for standing by. Welcome ...
Genmab reported strong Phase 3 trial results for epcoritamab in FL, secured FDA priority review, and raised its 2025 sales ...
NORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Thursday reported second-quarter earnings of $938 million. The North Chicago, Illinois-based company said it had net income ...
The global biopharma firm will build a new API production facility near its global headquarters in North Chicago.
Glenmark Pharmaceuticals to close ISB 2001 transaction in September, focusing on high-margin branded products for growth.
NORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Thursday reported second-quarter earnings of $938 million. The North Chicago, Illinois-based company said it had net ...
Quarter Diluted EPS of $0.52 on a GAAP Basis, a Decrease of 32.5 Percent; Adjusted Diluted EPS of $2.97, an Increase of 12.1 Percent; These Results Include an Unfav ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results